Ferroptosis and WDFY4 as novel targets for immunotherapy of lung adenocarcinoma.

导出 OA

翻译打印收藏纠错

第一作者： Ling,Huang

第一单位： State Key Laboratory of Trauma, Burns and Combined Injury, Department of Wound Infection and Drug, Daping Hospital, Army Medical University, Chongqing, China.

作者： Ling,Huang ^[1] ; Lifan,Zhong ^[2] ; Ruxin,Cheng ^[3] ; Limei,Chang ^[3] ; Mingyan,Qin ^[4] ; Huaping,Liang ^[2] ; Zhongkai,Liao ^[2]

作者单位： State Key Laboratory of Trauma, Burns and Combined Injury, Department of Wound Infection and Drug, Daping Hospital, Army Medical University, Chongqing, China. ^[1] Hainan Center for Drug and Medical Device Evaluation and Service, Hainan Medical Products Administration, Haikou, China. ^[2] School of Hainan Provincial Drug Safety Evaluation Research Center, Hainan Medical University, Haikou, China. ^[3] Emergency and Trauma College, Hainan Medical University, Haikou, Hainan, China. ^[4] Department of Thoracic Surgery, The Second Affiliated Hospital of Hainan Medical University, Haikou, China. ^[5]

关键词 Single Cell RNA-Sequencing WDFY4 ferroptosis immunotherapy lung adenocarcinoma

DOI 10.18632/aging.205042

PMID 37728413

发布时间 2023-10-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交